Welcome to our dedicated page for Harte Hanks SEC filings (Ticker: HHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for the numbers behind Harte Hanks� data-driven marketing engine? Investors typically open the company’s filings to see how cyclical client budgets affect revenue, whether Customer Care margins are expanding, and how logistics costs move the bottom line. Yet a single Harte Hanks annual report 10-K can exceed 250 pages—hardly light reading.
Stock Titan distills every Harte Hanks SEC filing into plain language. Our AI-powered summaries flag segment performance in the 10-K, spotlight cash-flow shifts in the Harte Hanks quarterly earnings report 10-Q filing, and translate 8-K material events explained in minutes. Need to monitor Harte Hanks insider trading Form 4 transactions? Receive real-time alerts the moment a director buys or sells. Curious about the proxy statement executive compensation tables? We highlight pay structures and incentive metrics without the jargon.
Use cases go further: track Harte Hanks executive stock transactions Form 4 to gauge management sentiment; compare marketing-services growth quarter over quarter with our earnings report filing analysis; or get notified when a new contract announcement hits EDGAR so you can act before the market does. Whether you’re understanding Harte Hanks SEC documents with AI or simply want Harte Hanks SEC filings explained simply, Stock Titan delivers every document�10-K, 10-Q, 8-K, Form 4—complete with expert context and historical trends, all updated in real time.
Form 4 overview: On 06/30/2025, UFP Industries (UFPI) Chief Financial Officer Michael R. Cole reported the acquisition of 14 phantom stock units at an implied price of $99.36 apiece through the company’s Deferred Compensation Plan. Each unit converts into one share of UFPI common stock upon the executive’s death, disability, or retirement.
After this transaction, Cole’s total beneficial ownership rises to 31,617 share-equivalents, all held directly. No open-market purchases or sales of common shares were disclosed, and there was no change in derivative positions other than the incremental award.
Given the transaction’s small dollar value (� $1.4 thousand) and its deferred settlement terms, the filing is regarded as routine and non-material for near-term valuation. Nonetheless, ongoing insider accumulation can be interpreted as continued management alignment with shareholder interests over the long run.